nodes	percent_of_prediction	percent_of_DWPC	metapath
Permethrin—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.52	1	CrCrCtD
Permethrin—CYP2B6—Tamoxifen—pancreatic cancer	0.119	0.289	CbGbCtD
Permethrin—CYP2B6—Irinotecan—pancreatic cancer	0.0912	0.222	CbGbCtD
Permethrin—CYP2B6—Doxorubicin—pancreatic cancer	0.0498	0.121	CbGbCtD
Permethrin—CYP3A4—Tamoxifen—pancreatic cancer	0.0365	0.0886	CbGbCtD
Permethrin—CYP3A4—Erlotinib—pancreatic cancer	0.031	0.0754	CbGbCtD
Permethrin—CYP3A4—Irinotecan—pancreatic cancer	0.028	0.0681	CbGbCtD
Permethrin—CYP3A4—Docetaxel—pancreatic cancer	0.0205	0.0499	CbGbCtD
Permethrin—CYP3A4—Sunitinib—pancreatic cancer	0.0204	0.0496	CbGbCtD
Permethrin—CYP3A4—Doxorubicin—pancreatic cancer	0.0153	0.0372	CbGbCtD
Permethrin—Numbness—Tamoxifen—pancreatic cancer	0.00285	0.0417	CcSEcCtD
Permethrin—Sensory loss—Tamoxifen—pancreatic cancer	0.00273	0.0399	CcSEcCtD
Permethrin—Tingling sensation—Fluorouracil—pancreatic cancer	0.00199	0.0291	CcSEcCtD
Permethrin—Stinging—Fluorouracil—pancreatic cancer	0.00197	0.0288	CcSEcCtD
Permethrin—Numbness—Fluorouracil—pancreatic cancer	0.00193	0.0282	CcSEcCtD
Permethrin—Sensory loss—Fluorouracil—pancreatic cancer	0.00184	0.027	CcSEcCtD
Permethrin—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00118	0.0173	CcSEcCtD
Permethrin—Erythema—Tamoxifen—pancreatic cancer	0.00103	0.0151	CcSEcCtD
Permethrin—Erythema—Erlotinib—pancreatic cancer	0.00102	0.015	CcSEcCtD
Permethrin—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00101	0.0148	CcSEcCtD
Permethrin—Stinging—Epirubicin—pancreatic cancer	0.00096	0.014	CcSEcCtD
Permethrin—Stinging—Doxorubicin—pancreatic cancer	0.000888	0.013	CcSEcCtD
Permethrin—Erythema—Sunitinib—pancreatic cancer	0.000885	0.0129	CcSEcCtD
Permethrin—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000798	0.0117	CcSEcCtD
Permethrin—Paraesthesia—Tamoxifen—pancreatic cancer	0.000758	0.0111	CcSEcCtD
Permethrin—Pain—Tamoxifen—pancreatic cancer	0.000721	0.0106	CcSEcCtD
Permethrin—Pain—Erlotinib—pancreatic cancer	0.000714	0.0104	CcSEcCtD
Permethrin—Erythema—Gemcitabine—pancreatic cancer	0.00071	0.0104	CcSEcCtD
Permethrin—Erythema—Fluorouracil—pancreatic cancer	0.000698	0.0102	CcSEcCtD
Permethrin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00069	0.0101	CcSEcCtD
Permethrin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000683	0.00998	CcSEcCtD
Permethrin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000667	0.00975	CcSEcCtD
Permethrin—Abdominal pain—Erlotinib—pancreatic cancer	0.00066	0.00965	CcSEcCtD
Permethrin—Body temperature increased—Erlotinib—pancreatic cancer	0.00066	0.00965	CcSEcCtD
Permethrin—Paraesthesia—Sunitinib—pancreatic cancer	0.000649	0.00949	CcSEcCtD
Permethrin—Pain—Sunitinib—pancreatic cancer	0.000618	0.00904	CcSEcCtD
Permethrin—Pruritus—Tamoxifen—pancreatic cancer	0.000597	0.00873	CcSEcCtD
Permethrin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000591	0.00864	CcSEcCtD
Permethrin—Pruritus—Erlotinib—pancreatic cancer	0.000591	0.00864	CcSEcCtD
Permethrin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000577	0.00844	CcSEcCtD
Permethrin—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000576	0.00843	CcSEcCtD
Permethrin—Abdominal pain—Sunitinib—pancreatic cancer	0.000571	0.00835	CcSEcCtD
Permethrin—Body temperature increased—Sunitinib—pancreatic cancer	0.000571	0.00835	CcSEcCtD
Permethrin—Diarrhoea—Erlotinib—pancreatic cancer	0.000571	0.00835	CcSEcCtD
Permethrin—Dizziness—Tamoxifen—pancreatic cancer	0.000558	0.00816	CcSEcCtD
Permethrin—Dizziness—Erlotinib—pancreatic cancer	0.000552	0.00807	CcSEcCtD
Permethrin—Vomiting—Tamoxifen—pancreatic cancer	0.000536	0.00784	CcSEcCtD
Permethrin—Paraesthesia—Irinotecan—pancreatic cancer	0.000534	0.00782	CcSEcCtD
Permethrin—Rash—Tamoxifen—pancreatic cancer	0.000532	0.00778	CcSEcCtD
Permethrin—Dermatitis—Tamoxifen—pancreatic cancer	0.000531	0.00777	CcSEcCtD
Permethrin—Vomiting—Erlotinib—pancreatic cancer	0.000531	0.00776	CcSEcCtD
Permethrin—Headache—Tamoxifen—pancreatic cancer	0.000528	0.00773	CcSEcCtD
Permethrin—Rash—Erlotinib—pancreatic cancer	0.000526	0.0077	CcSEcCtD
Permethrin—Dermatitis—Erlotinib—pancreatic cancer	0.000526	0.00769	CcSEcCtD
Permethrin—Headache—Erlotinib—pancreatic cancer	0.000523	0.00765	CcSEcCtD
Permethrin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000521	0.00761	CcSEcCtD
Permethrin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000512	0.00749	CcSEcCtD
Permethrin—Pruritus—Sunitinib—pancreatic cancer	0.000511	0.00748	CcSEcCtD
Permethrin—Pain—Irinotecan—pancreatic cancer	0.000509	0.00744	CcSEcCtD
Permethrin—Erythema—Docetaxel—pancreatic cancer	0.000504	0.00737	CcSEcCtD
Permethrin—Nausea—Tamoxifen—pancreatic cancer	0.000501	0.00733	CcSEcCtD
Permethrin—Pain—Gemcitabine—pancreatic cancer	0.000496	0.00725	CcSEcCtD
Permethrin—Nausea—Erlotinib—pancreatic cancer	0.000496	0.00725	CcSEcCtD
Permethrin—Diarrhoea—Sunitinib—pancreatic cancer	0.000494	0.00723	CcSEcCtD
Permethrin—Pain—Fluorouracil—pancreatic cancer	0.000487	0.00713	CcSEcCtD
Permethrin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000487	0.00712	CcSEcCtD
Permethrin—Dizziness—Sunitinib—pancreatic cancer	0.000478	0.00699	CcSEcCtD
Permethrin—Abdominal pain—Irinotecan—pancreatic cancer	0.000471	0.00688	CcSEcCtD
Permethrin—Body temperature increased—Irinotecan—pancreatic cancer	0.000471	0.00688	CcSEcCtD
Permethrin—Vomiting—Sunitinib—pancreatic cancer	0.000459	0.00672	CcSEcCtD
Permethrin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000458	0.0067	CcSEcCtD
Permethrin—Rash—Sunitinib—pancreatic cancer	0.000456	0.00666	CcSEcCtD
Permethrin—Dermatitis—Sunitinib—pancreatic cancer	0.000455	0.00666	CcSEcCtD
Permethrin—Headache—Sunitinib—pancreatic cancer	0.000453	0.00662	CcSEcCtD
Permethrin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000451	0.00659	CcSEcCtD
Permethrin—Nausea—Sunitinib—pancreatic cancer	0.000429	0.00628	CcSEcCtD
Permethrin—Pruritus—Gemcitabine—pancreatic cancer	0.00041	0.006	CcSEcCtD
Permethrin—Diarrhoea—Irinotecan—pancreatic cancer	0.000407	0.00596	CcSEcCtD
Permethrin—Pruritus—Fluorouracil—pancreatic cancer	0.000403	0.0059	CcSEcCtD
Permethrin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000397	0.0058	CcSEcCtD
Permethrin—Dizziness—Irinotecan—pancreatic cancer	0.000394	0.00576	CcSEcCtD
Permethrin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00039	0.0057	CcSEcCtD
Permethrin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000389	0.00568	CcSEcCtD
Permethrin—Vomiting—Irinotecan—pancreatic cancer	0.000378	0.00553	CcSEcCtD
Permethrin—Dizziness—Fluorouracil—pancreatic cancer	0.000377	0.00551	CcSEcCtD
Permethrin—Rash—Irinotecan—pancreatic cancer	0.000375	0.00549	CcSEcCtD
Permethrin—Dermatitis—Irinotecan—pancreatic cancer	0.000375	0.00548	CcSEcCtD
Permethrin—Headache—Irinotecan—pancreatic cancer	0.000373	0.00545	CcSEcCtD
Permethrin—Paraesthesia—Docetaxel—pancreatic cancer	0.000369	0.0054	CcSEcCtD
Permethrin—Vomiting—Gemcitabine—pancreatic cancer	0.000369	0.00539	CcSEcCtD
Permethrin—Rash—Gemcitabine—pancreatic cancer	0.000366	0.00535	CcSEcCtD
Permethrin—Dermatitis—Gemcitabine—pancreatic cancer	0.000365	0.00534	CcSEcCtD
Permethrin—Headache—Gemcitabine—pancreatic cancer	0.000363	0.00531	CcSEcCtD
Permethrin—Vomiting—Fluorouracil—pancreatic cancer	0.000362	0.0053	CcSEcCtD
Permethrin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00036	0.00526	CcSEcCtD
Permethrin—Rash—Fluorouracil—pancreatic cancer	0.000359	0.00526	CcSEcCtD
Permethrin—Dermatitis—Fluorouracil—pancreatic cancer	0.000359	0.00525	CcSEcCtD
Permethrin—Headache—Fluorouracil—pancreatic cancer	0.000357	0.00522	CcSEcCtD
Permethrin—Nausea—Irinotecan—pancreatic cancer	0.000354	0.00517	CcSEcCtD
Permethrin—Pain—Docetaxel—pancreatic cancer	0.000352	0.00515	CcSEcCtD
Permethrin—Nausea—Gemcitabine—pancreatic cancer	0.000344	0.00504	CcSEcCtD
Permethrin—Erythema—Epirubicin—pancreatic cancer	0.00034	0.00497	CcSEcCtD
Permethrin—Nausea—Fluorouracil—pancreatic cancer	0.000339	0.00495	CcSEcCtD
Permethrin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000336	0.00492	CcSEcCtD
Permethrin—Body temperature increased—Docetaxel—pancreatic cancer	0.000325	0.00476	CcSEcCtD
Permethrin—Abdominal pain—Docetaxel—pancreatic cancer	0.000325	0.00476	CcSEcCtD
Permethrin—Erythema—Doxorubicin—pancreatic cancer	0.000315	0.0046	CcSEcCtD
Permethrin—Pruritus—Docetaxel—pancreatic cancer	0.000291	0.00426	CcSEcCtD
Permethrin—Diarrhoea—Docetaxel—pancreatic cancer	0.000282	0.00412	CcSEcCtD
Permethrin—Dizziness—Docetaxel—pancreatic cancer	0.000272	0.00398	CcSEcCtD
Permethrin—Vomiting—Docetaxel—pancreatic cancer	0.000262	0.00383	CcSEcCtD
Permethrin—Rash—Docetaxel—pancreatic cancer	0.000259	0.00379	CcSEcCtD
Permethrin—Dermatitis—Docetaxel—pancreatic cancer	0.000259	0.00379	CcSEcCtD
Permethrin—Headache—Docetaxel—pancreatic cancer	0.000258	0.00377	CcSEcCtD
Permethrin—Paraesthesia—Epirubicin—pancreatic cancer	0.000249	0.00364	CcSEcCtD
Permethrin—Nausea—Docetaxel—pancreatic cancer	0.000244	0.00357	CcSEcCtD
Permethrin—Pain—Epirubicin—pancreatic cancer	0.000237	0.00347	CcSEcCtD
Permethrin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000231	0.00337	CcSEcCtD
Permethrin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000227	0.00332	CcSEcCtD
Permethrin—Pain—Doxorubicin—pancreatic cancer	0.00022	0.00321	CcSEcCtD
Permethrin—Body temperature increased—Epirubicin—pancreatic cancer	0.000219	0.00321	CcSEcCtD
Permethrin—Abdominal pain—Epirubicin—pancreatic cancer	0.000219	0.00321	CcSEcCtD
Permethrin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00021	0.00307	CcSEcCtD
Permethrin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000203	0.00297	CcSEcCtD
Permethrin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000203	0.00297	CcSEcCtD
Permethrin—Pruritus—Epirubicin—pancreatic cancer	0.000196	0.00287	CcSEcCtD
Permethrin—Diarrhoea—Epirubicin—pancreatic cancer	0.00019	0.00278	CcSEcCtD
Permethrin—Dizziness—Epirubicin—pancreatic cancer	0.000184	0.00268	CcSEcCtD
Permethrin—Pruritus—Doxorubicin—pancreatic cancer	0.000182	0.00266	CcSEcCtD
Permethrin—Vomiting—Epirubicin—pancreatic cancer	0.000176	0.00258	CcSEcCtD
Permethrin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000176	0.00257	CcSEcCtD
Permethrin—Rash—Epirubicin—pancreatic cancer	0.000175	0.00256	CcSEcCtD
Permethrin—Dermatitis—Epirubicin—pancreatic cancer	0.000175	0.00256	CcSEcCtD
Permethrin—Headache—Epirubicin—pancreatic cancer	0.000174	0.00254	CcSEcCtD
Permethrin—Dizziness—Doxorubicin—pancreatic cancer	0.00017	0.00248	CcSEcCtD
Permethrin—Nausea—Epirubicin—pancreatic cancer	0.000165	0.00241	CcSEcCtD
Permethrin—Vomiting—Doxorubicin—pancreatic cancer	0.000163	0.00239	CcSEcCtD
Permethrin—Rash—Doxorubicin—pancreatic cancer	0.000162	0.00237	CcSEcCtD
Permethrin—Dermatitis—Doxorubicin—pancreatic cancer	0.000162	0.00237	CcSEcCtD
Permethrin—Headache—Doxorubicin—pancreatic cancer	0.000161	0.00235	CcSEcCtD
Permethrin—Nausea—Doxorubicin—pancreatic cancer	0.000153	0.00223	CcSEcCtD
